Department of Physical Medicine and Rehabilitation, Sports Medicine Research Institute, The Ohio State University, Columbus, Ohio, USA.
Department of Orthopaedics, Sports Medicine Research Institute, The Ohio State University, Columbus, Ohio, USA.
Am J Sports Med. 2022 Jan;50(1):273-281. doi: 10.1177/0363546521998010. Epub 2021 Apr 8.
Platelet-rich plasma (PRP) and hyaluronic acid (HA) are injectable treatments for knee osteoarthritis. The focus of previous studies has compared their efficacy against each other as monotherapy. However, a new trend of combining these 2 injections has emerged in an attempt to have a synergistic effect.
To systematically review the clinical literature examining the combined use of PRP + HA.
Systematic review.
A systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using PubMed and Embase. The following search terms were used: knee osteoarthritis AND platelet rich plasma AND hyaluronic acid. The review was performed by 2 independent reviewers who applied the inclusion/exclusion criteria and independently extracted data, including methodologic scoring, PRP preparation technique, HA composition, and patient-reported outcomes (PROs).
A total of 431 articles were screened, 12 reviewed in full, and 8 included in the final analysis: 2 case series, 3 comparative, and 3 randomized studies. Average follow-up was 9 months. The modified Coleman Methodology Score was 38.13 ± 13.1 (mean ± SD). Combination therapy resulted in improved PROs in all studies. Of the comparative and randomized studies, 2 demonstrated that combination therapy was superior to HA alone. However, when PRP alone was used as the control arm (4 studies), combination therapy was not superior to PRP alone.
Combination therapy with PRP + HA improves PROs and is superior to HA alone but is not superior to PRP alone.
富血小板血浆(PRP)和透明质酸(HA)是治疗膝骨关节炎的注射疗法。既往研究的重点是将它们作为单药治疗进行疗效比较。然而,一种将这 2 种注射剂联合使用的新趋势已经出现,试图产生协同作用。
系统回顾检查 PRP+HA 联合使用的临床文献。
系统回顾。
根据 PRISMA(系统评价和荟萃分析的首选报告项目)指南,使用 PubMed 和 Embase 进行系统回顾。使用以下搜索词:膝骨关节炎 AND 富血小板血浆 AND 透明质酸。由 2 位独立的评审员应用纳入/排除标准并独立提取数据,包括方法学评分、PRP 制备技术、HA 成分和患者报告的结局(PROs)。
共筛选出 431 篇文章,其中 12 篇进行了全面审查,最终有 8 篇纳入分析:2 篇病例系列研究、3 篇对照研究和 3 篇随机研究。平均随访时间为 9 个月。改良 Coleman 方法学评分平均为 38.13±13.1(均数±标准差)。联合治疗在所有研究中均改善了 PROs。在对照研究和随机研究中,有 2 项研究表明联合治疗优于单独使用 HA。然而,当单独使用 PRP 作为对照臂(4 项研究)时,联合治疗并不优于单独使用 PRP。
PRP+HA 联合治疗可改善 PROs,优于单独使用 HA,但并不优于单独使用 PRP。